loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of EIDD 2801 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    EIDD 2801

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 542Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Lagevrio

    02 1Molnupiravir

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Molnupiravir

    Molnupiravir

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Molnupiravir

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Merck

    Molnupiravir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 952

    2020 Revenue in Millions : 0

    Growth (%) : New Launch in 2021

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Lagevrio

    Molnupiravir

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Lagevrio

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Merck & Co.

    Molnupiravir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 5,684

    2021 Revenue in Millions : 952

    Growth (%) : 497

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Lagevrio

    Molnupiravir

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Lagevrio

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Merck & Co.

    Molnupiravir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 1,428

    2022 Revenue in Millions : 5,684

    Growth (%) : -75

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF